Name: Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
Start: 2025-04-30T08:00:00+00:00
End: 2025-04-30T17:00:00+00:00

All Events

This event has passed.

Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults

April 30, 2025 @ 8:00 am - 5:00 pm

Date: April 30th

Presenter: P.J. (Paul) Wichgers Schreur, Wageningen Bioveterinary Research, Netherlands

Title: Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults

Recordings: Available here.

Event Navigation

RSV Vaccines
Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults